← All trials
NCT01975064
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2013
- Primary completion
- Dec 1, 2017
- Completion date
- Dec 1, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- 8000
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Uppsala UniversityLead sponsor
- Wroclaw Medical UniversityCollaborator
- Sundsvall HospitalCollaborator
- Linkoping UniversityCollaborator
- Orebro UniversityCollaborator
- Kalmar County HospitalCollaborator
- Helsingborgs HospitalCollaborator
- Peking UniversityCollaborator
- Lund UniversityCollaborator
- Uppsala UniversityOverall official - principal investigator
- Uppsala UniversityStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.